Tyra Biosciences Inc
TYRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.91B
Close$
$1.20
96.1% downside
Current Fair Value
96.1% downsideOvervalued by 96.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.91 Billion |
|---|---|
| Enterprise Value | $1.83 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.01 |
| Beta | 0.76 |
| Outstanding Shares | 61,746,050 |
Return
| Return on Equity | -33.83% |
|---|---|
| Return on Assets | -31.82% |
| Return on Invested Capital | -33.90% |
Valuation & Multiples
| P/E Ratio | -14.74 |
|---|---|
| PEG | -37.18 |
| Price to Sales | - |
| Price to Book Ratio | 5.13 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -13.75 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 143.70% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.30%▼ 109.33% |
|---|---|
| Total Invested | $25.62M▼ 98.99% |
| Investors Holding | 8▼ 164.00% |
ESG Score
No data
About Tyra Biosciences Inc
2,021 employees